OR Edge Morning Report | Issue 009 Tuesday, April 28, 2026 | 6:00 AM EST

Guiding Every Case to Certainty and Calm

Yetsenia Tyson, RN

Estimated Reading Time: 12 minutes

Someone is coming for your independent ASC.

Not next year. Not when the market softens. Right now, in 2026, your schedule is full, your surgeons are happy, and your center is performing well.

The consolidation pressure on independent ambulatory surgery centers is not a future threat. For independent centers, the question is no longer whether consolidation is coming, but how soon they may be next.

In June 2025, Ascension signed a definitive agreement to acquire AmSurg, a major ASC operator with 250 locations nationwide. The transaction expanded Ascension's ASC footprint from 58 to more than 300 centers in 34 states, positioning the Catholic health system as a direct competitor to Tenet Healthcare's United Surgical Partners International. That deal was valued at $3.9 billion.

In a 2025 VMG Health survey of health system executives, outpatient surgery ranked as the top service line for joint venture partnerships, with more than 60% of respondents indicating ASCs were a top interest for their growth.

The market is moving around you whether you are at the table or not.

This issue is not about whether you should sell. That is a decision that belongs to you, your partners, and your surgeons. This issue is about what you need to protect before that conversation ever starts, and what the independent centers that have survived consolidation pressure have in common.

The playing field is not level. The workflow has to compensate for that gap.

Why 2026 is different from every previous consolidation wave

ASC consolidation is not new. What is new in 2026 is who is doing the buying and why.

Previous consolidation waves were driven primarily by private equity looking for platform plays and roll-up opportunities. The current wave is being driven by a different and more structurally powerful force: payers.

After being bought by UnitedHealth Group's health services subsidiary Optum, ASC prices rose an average of 11%. UnitedHealth Group paid approximately $2.3 billion for Surgical Care Affiliates in 2017 and rebranded it as SCA Health. SCA Health now supports a network of over 300 ASCs across 35 states.

When a payer owns the ASC, it captures margin on both sides of the transaction. When their enrollees go to a payer-owned ASC instead of a hospital, the payer spends less on the insurance side and profits on the provider side simultaneously. Healthcare economists describe this as a payor model where payers that invest in ASC facilities get the best of both worlds.

That model creates a structural pressure on independent ASCs that private equity consolidation never did. Private equity buyers wanted your EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), the core profitability metric against which your center's financial health is measured. Payer buyers want your patient volume, your surgeon relationships, and your managed care contract leverage. Those are harder to replicate and harder to recover once lost.

By 2024, just 42.2% of physicians worked in private practices, down from 60.1% in 2012. The trajectory is not ambiguous. The question for your independent center is whether you are building the operational and financial infrastructure that makes independence sustainable, or whether you are running on momentum that consolidation pressure will eventually erode.

What the floor is telling me

The consolidation conversation seldom starts in the administrator's office. It starts in the parking lot after a difficult payer negotiation. It starts when a surgeon mentions that a health system called. It starts when the billing team reports that a managed care contract renewal came back with terms that make the case mix math uncomfortable.

By the time the conversation reaches the boardroom, the pressure has usually been building for months. And the centers that navigate it best are not the ones with the most sophisticated legal counsel or the most experienced transaction advisors. They are the ones that already know their numbers, already have their operational story documented, and already understand what they are worth before someone else tells them.

That preparation does not happen in the 90 days before a letter of intent arrives. It happens in the Tuesday morning huddle. It happens in the pre-op workflow. It happens in every quality measure that gets submitted correctly and every cancellation that gets prevented before it costs the center $2,000 to $10,000 in lost OR time.

Your operational excellence is your negotiating leverage. Whether you use it to stay independent or to negotiate from strength in a partnership conversation, it has to exist before the conversation begins.

The three ASCQR failure patterns most common in independent ASCs

These are the specific gaps that cost independent centers their full payment update most consistently.

The three things consolidators look for first

Understanding what a health system or large platform operator evaluates when they look at an independent ASC tells you exactly what to build before the conversation starts.

One: Payer contract quality and managed care leverage

The first thing any sophisticated buyer evaluates is your payer mix and contract rates. Independent ASCs typically negotiate managed care contracts from a position of relative weakness because they lack the multi-facility leverage that health systems and large platforms bring to the table. Nearly 80% of physicians who cited the need for better leverage in payer negotiations said it was a very important or important reason in the sale of their private practice.

If your managed care contracts have not been renegotiated in the past three years, your rates are almost certainly below what your case mix and quality outcomes could support. That gap represents both a current revenue leak and a valuation discount when a buyer models your center's performance.

Audit your top five payer contracts this quarter. Know your rates relative to Medicare for each procedure category. Know your denial rates by payer. That data is your leverage in a partnership conversation and in every contract renewal that precedes it.

Two: Surgeon alignment and case volume stability

Industry reactions to major ASC acquisitions range from excitement to caution, with some leaders warning that acquirers must preserve physician-centric culture rather than impose a hospital-centric model. The reason that a warning gets issued repeatedly is that surgeon relationships are the single most valuable and most fragile asset any ASC carries.

A consolidator acquiring your center is acquiring your surgeon relationships. If those relationships are strong, exclusive, and producing growing case volume, your center is worth more. If your top three surgeons are already talking to competing systems, your case volume is at risk regardless of who owns the facility.

Document your surgeon relationship quality now. Not informally; formally. Know which surgeons are performing what volume, what their satisfaction level is with your operational performance, and what they need from your center that they are not currently receiving. That documentation protects you in a partnership negotiation and guides your operational investment decisions independently of any transaction.

Three: Operational efficiency and cancellation rate

Every sophisticated buyer models cancellation rate and case efficiency as part of their acquisition analysis. A center with a 4% same-day cancellation rate is operationally and financially different from a center with an 8% rate. That difference shows up directly in Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA), in surgeon satisfaction, and in the narrative a buyer constructs about operational risk.

ASC transaction activity in 2025 reflected a market shaped by ongoing consolidation among scaled operators, increased health system participation, and targeted private equity investment in specialty-focused platforms. The centers commanding the strongest transaction valuations are the ones with documented operational discipline, not just strong revenue.

Your pre-op workflow is your operational story. Your cancellation rate, your authorization approval rate, your medication reconciliation accuracy, your day-of-surgery readiness rate; these are not just clinical metrics. They are the data points a buyer uses to assess what your center is worth and what it will cost to operate after acquisition.

Build that story now. Whether you are protecting independence or preparing for a strategic partnership, the operational documentation you build in 2026 is the foundation of every conversation that follows.

What independent ASCs that survived consolidation pressure have in common

The research on this is consistent across market cycles. Independent ASCs that maintained their independence through consolidation waves share four characteristics.

They have physician partners who are financially invested in the center's independence and operationally engaged in its performance. Passive physician partners are the first vulnerability a consolidator identifies.

They have payer contracts that are reviewed and renegotiated on a regular cycle, not left to auto-renew at rates that no longer reflect market conditions or the center's quality profile.

They have operational metrics that are tracked, documented, and shared with physician partners in a format that tells a clear performance story. Centers that cannot produce a one-page operational summary on short notice are centers that cannot defend their value in a negotiation.

And they have made deliberate investments in the workflows that protect surgical revenue: pre-op readiness, authorization management, quality reporting, and case efficiency. Not because a buyer asked for them. Because those investments produce better patient outcomes and stronger financial performance, which are the same thing at an operational scale.

FROM THE OR FLOOR

I have worked alongside nurses who have watched their centers change ownership. The clinical work did not stop. The patients still came through the door. The cases still got done.

But something changed. The decisions that used to happen in a Tuesday morning huddle started happening in a corporate office in another city. The administrator who knew every surgeon by name was replaced by a regional operations manager who knew the center by its EBITDA(Earnings Before Interest, Taxes, Depreciation, and Amortization) contribution. The culture that attracted the best nurses and the most loyal surgeons started to feel like something that had to be defended rather than something that simply existed.

Independence is not just a financial structure. It is a clinical culture. And in 2026, that culture is worth protecting with the same discipline and intentionality that you bring to every pre-op checklist.

Build the operational infrastructure that makes your independence undeniable. Know your numbers. Document your story. Protect your surgeon relationships. And make sure that when the conversation about your center's future happens, you are the one who starts it.

What to do this week

Pull your cancellation rate data for the past 90 days. Separate it by cancellation reason, day-of-surgery patient issues, authorization failures, documentation gaps, and scheduling errors. That breakdown tells you exactly where your operational story is strongest and where it needs investment before anyone else tells you.

Then ask your administrator one question: if a health system called tomorrow and asked for a 90-day operational overview, could we produce one by the end of the week?

If the answer is no, that is not a transaction preparation problem. That is an operational infrastructure problem. And it is solvable before the call comes.

The operational story that protects you in both directions

Whether your goal is to protect your independence or to negotiate from strength in a future partnership conversation, the foundation is identical. You need a documented, real-time picture of your pre-op operational performance. Not a narrative. Not a general sense of how cases are running. Specific, measurable data that tells the story of your center's readiness, efficiency, and clinical discipline in a format that survives scrutiny.

That story is built in the 14 days before each case. In the medication reconciliation, that catches the SGLT-2 inhibitor is caught before the morning of surgery. In the authorization confirmation that is tracked to expiration rather than filed and forgotten. In the NPO verification that happens the evening before, rather than at the registration desk at 6:45 AM. In the clearance confirmation that closes the loop between the referring physician and the surgical team before the patient arrives.

Every one of those workflow steps produces data. Whether that data is being captured, organized, and made visible to your leadership team is the difference between a center that can tell its own story and a center that waits for someone else to tell it.

Independent ASCs in South Florida are operating in one of the most actively contested outpatient surgery markets in the United States. Baptist Health South Florida, HCA Healthcare, Broward Health, and Memorial Health System are all expanding their outpatient surgical footprint in 2026. The conversation about your center's future is not hypothetical. It is a matter of timing.

The centers that navigate that conversation from strength are the ones that have already built the operational infrastructure that makes their performance visible, measurable, and defensible. Not in a data room during the transaction process. In the daily workflow that produces results before anyone asks to see them.

That is exactly what Haleris was built to do. If you are an independent ASC administrator who wants to see what that operational picture looks like for your center, reply to this email. I am selecting a small number of South Florida pilot partners for early access this year, and every conversation starts with a floor-level look at your current pre-op workflow.

Curated intelligence from the perioperative space this week.

The Ascension-AmSurg Close: The $3.9 billion acquisition of AmSurg by Ascension was expected to close in early 2026, expanding Ascension's ASC footprint from 58 to more than 300 centers in 34 states. If you are an independent center in a market where AmSurg previously operated, your competitive landscape has shifted. A nonprofit health system with payer integration and value-based infrastructure now has a presence in your market that a private equity-backed operator did not.

The Optum Price Effect: A February 2026 study published in Health Affairs found that after Optum acquired ASCs, prices charged to non-UnitedHealthcare commercial insurers rose an average of 11%. That finding matters for independent centers negotiating managed care contracts in markets where Optum-owned ASCs are present. Your payer knows what the consolidated competitor charges. Your negotiation starts from that baseline.

The Physician Ownership Trajectory: In 2024, just 42.2% of physicians worked in private practice, down from 60.1% in 2012. That trajectory has direct implications for independent ASC physician ownership structures. Centers that are actively recruiting physician partners and structuring ownership in ways that align financial incentives with operational performance are building a moat that consolidators find significantly more difficult to breach.

The South Florida Dimension: Baptist Health South Florida, HCA Healthcare, Broward Health, and Memorial Health System are all actively expanding their outpatient surgical footprint in 2026. Independent ASCs in Miami-Dade, Broward, and Palm Beach counties are not navigating a national consolidation trend. They are navigating a local one, with specific health systems that have identified outpatient surgery as a strategic growth priority in your exact market.

Free. No fluff. Written from the floor by a perioperative RN living the same reality you are every single day.

Pull your cancellation data this week. Reply and tell me what you find.

Brief comment before closing out this edition!

Consolidation is not something that happens to a center. It is something that happens to a center that was not ready for the conversation.

The independent ASCs that are navigating this environment from a position of strength right now are not the largest ones or the most well-funded ones. They are the ones where leadership made a decision, quietly, without fanfare, to build the operational infrastructure that makes their performance visible before anyone asked to see it.

That decision does not require a transaction advisor or a legal team. It requires a Tuesday morning huddle where someone asks: what does our cancellation data look like this month; what does our authorization approval rate tell us, and what would we show a health system executive if they walked through our door tomorrow?

If your center cannot answer those three questions with confidence today, that is not a crisis. It is a starting point. And the starting point is always the same: build the workflow before the conversation arrives.

I would love to hear where your center stands right now. Are you focused on protecting your independence, quietly exploring your options, or somewhere in between? Reply to this email and tell me. Every response I receive shapes what I write next. Your voice matters here.

What to watch in Issue 010

The supply chain pressure on independent ASCs is accelerating in 2026. Medical supply costs are projected to increase 2.41% this year, and tariff impacts on surgical supplies are creating procurement volatility that independent centers without group purchasing organization leverage are absorbing alone. Issue 010 covers what independent ASCs are actually doing right now to protect per-case margin when they do not have hospital-level purchasing power, and the specific supply categories where the cost exposure is highest.

Forward this issue to your ASC administrator or director of nursing. This is the conversation your leadership team needs to have before the next partnership inquiry arrives.

See you Tuesday at 6:00 AM EST.

With purpose,

Yetsenia Tyson, RN.

Founder and CEO.

Haleris OR Edge Morning Report

oredgemorningreport.com

Sources and Methodology

All data cited in this issue is sourced from verifiable published references. Every statistic is verified against its source before publication.

OR Edge Morning Report maintains a strict data integrity standard. We verify every statistic against its source before publication. If you identify a discrepancy, please reply directly to this email.